Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Operating Cash Flow Growth
-7.78%
TTM · Period ending:
BIO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.78%period ending
Latest reported-7.78%period ending
BIO TTM Cash from Operations YoY % (-65.31% → -7.78%)
Year-over-year change
High-resolution chart · PNG
BIO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 12.347% | |
| -14.5429% | |
| -46.1178% | |
| 17.9738% | |
| 32.9242% | |
| 31.1736% | |
| 64.8352% | |
| 67.3171% | |
| 50.6849% | |
| 32.7189% | |
| 29.3839% | |
| -18% | |
| 32.7273% | |
| -9.9585% | |
| -36.4458% | |
| -36.8687% | |
| -61.9816% | |
| -36.7454% | |
| -13.089% | |
| 13.7931% | |
| 16.9811% | |
| -8.8517% | |
| -20.911% | |
| -39.3728% | |
| -32.0513% | |
| 5.5556% | |
| 114.6667% | |
| 752.2727% | |
| 950% | |
| 842.8571% | |
| 462.5% | |
| -140.553% | |
| 147.619% | |
| -26.3158% | |
| -2.439% | |
| 7,333.3333% | |
| -58.8235% | |
| 50% | |
| -66.1157% | |
| -102.2727% | |
| -65.3061% |